Massachusetts General Hospital is the original and largest teaching hospital of Harvard Medical School located in the West End neighborhood of Boston, Massachusetts. It is the third oldest general hospital in the United States and has a capacity of 999 beds.

There are 999 beds in Massachusetts General Hospital.

During the past decade, Massachusetts General Hospital conducted 2183 clinical trials. In the 10-year time frame, 2183 clinical trials started and 1161 clinical trials were completed, i.e. on average, 53.2% percent of trials that started reached the finish line to date. In the past 5 years, 943 clinical trials started and 585 clinical trials were completed. i.e. 62% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Massachusetts General Hospital" #1 sponsor was "Massachusetts General Hospital" with 1454 trials, followed by "Dana-Farber Cancer Institute" with 209 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 98 trials sponsored, "Pfizer" with 73 trials sponsored and "Hoffmann-La Roche" with 73 trials sponsored. Other sponsors include 2081 different institutions and companies that sponsored additional 876 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Massachusetts General Hospital" #1 collaborator was "Massachusetts General Hospital" with 292 trials as a collaborator, "Brigham and Women's Hospital" with 181 trials as a collaborator, "National Cancer Institute (NCI)" with 160 trials as a collaborator, "Beth Israel Deaconess Medical Center" with 137 trials as a collaborator and "Dana-Farber Cancer Institute" with 115 trials as a collaborator. Other collaborators include 3003 different institutions and companies that were collaborators in the rest 1080 trials.

According to Clinical.Site data, the most researched conditions in "Massachusetts General Hospital" are "Breast Cancer" (146 trials), "HIV Infections" (98 trials), "Multiple Myeloma" (77 trials), "Depression" (63 trials) and "Ovarian Cancer" (63 trials). Many other conditions were trialed in "Massachusetts General Hospital" in a lesser frequency.

Most popular intervention types in "Massachusetts General Hospital" are "Drug" (2285 trials), "Device" (519 trials), "Other" (454 trials), "Behavioral" (300 trials) and "Biological" (279 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (441 trials), "Pembrolizumab" (61 trials), "Nivolumab" (56 trials), "Bevacizumab" (48 trials) and "Paclitaxel" (46 trials). Other intervention names were less common.

The vast majority of trials in "Massachusetts General Hospital" are 3596 trials for "All" genders, 276 trials for "Female" genders and 95 trials for "Male" genders.

Currently, there are 1206 active trials in "Massachusetts General Hospital". 32 are not yet recruiting, 668 are recruiting, 466 are Active, not recruiting, and 40 are Enrolling by invitation. In total, there were 2081 completed trials in Massachusetts General Hospital, 16 suspended trials, and 391 terminated clinical trials to date.

Out of the total trials that were conducted in Massachusetts General Hospital, 715 "Phase 1" clinical trials were conducted, 1238 "Phase 2" clinical trials and 550 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 216 trials, and there were also 968 trials that are defined as “Not Applicable".

Massachusetts General Hospital has several departments that took part in Clinical trials: "Massachusetts General Hospital Cancer Center" - 560 trials, "Mass General North Shore Cancer Center" - 48 trials, "Massachusetts General Hospital Depression Clinical and Research Program" - 25 trials, "Clinical Unit for Research Trials in Skin" - 22 trials, "Massachusetts General Hospital for Children" - 18 trials, "Massachusetts General Hospital Cystic Fibrosis Center Clinical Rsearch Center" - 11 trials, "Dauten Family Center for Bipolar Treatment Innovation" - 10 trials, "Massachusetts General Hospital, Lurie Center for Autism" - 10 trials, "MGH Center for Translational Pain Research" - 9 trials, "Massachusetts General Hospital-Genetics-Site Number:840062" - 7 trials, "MGH Diabetes Research Center" - 6 trials, "Massachusetts General Hospital- Center for Anxiety and Traumatic Stress Disorders" - 6 trials, "Massachusetts General Hospital, Neuroendocrine Unit" - 5 trials, "Healey Center for ALS at Mass General" - 5 trials, "Massachusetts General Hospital Translational and Clinical Research Center" - 4 trials, "Massachusetts General Hospital Heart Center" - 4 trials, "Massachusetts General Hospital - Center For Addiction Medicine" - 4 trials, "Massachusetts General Hospital" - 4 trials, "Massachusetts General Hospital Burn Unit" - 4 trials, "Massachusetts General Hospital, Neurology Clinical Trials Unit" - 4 trials, "Massachusetts General Hospital - Infectious Diseases" - 4 trials, "Reproductive Endocrine Unit, Massachusetts General Hospital" - 4 trials, "Massachusetts General Hospital Clinical Trials Pharmacy" - 3 trials, "Freedom Trail Clinic, Massachusetts General Hospital" - 3 trials, "The Depression Clinical and Research Program, Massachusetts General Hospital" - 3 trials